Familial Mediterranean fever and microRNAs

Aslihan Esra Bildirici1

  • 1Sivas University of Science and Technology, Sivas, Türkiye.

Insights

Familial Mediterranean Fever (FMF) is an inherited disease linked to MEFV gene mutations. MicroRNAs (miRNAs) are explored for their role in FMF pathogenesis and potential as diagnostic and therapeutic agents.

Area of Science:

  • Genetics
  • Molecular Biology
  • Immunology

Background:

  • Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disorder caused by MEFV gene mutations, affecting over 100,000 people globally.
  • The disease significantly impacts patient quality of life and healthcare systems, with varying penetrance suggesting additional contributing factors.
  • Epigenetic modifications, particularly microRNAs (miRNAs), are increasingly recognized for their role in gene expression regulation and disease pathogenesis.

Purpose of the Study:

  • To review recent research on the involvement of microRNAs (miRNAs) in the pathogenesis of Familial Mediterranean Fever (FMF).
  • To discuss the potential of miRNAs as biomarkers for FMF diagnosis.
  • To explore the therapeutic implications of miRNAs in managing FMF.

Main Methods:

  • Comprehensive literature review of studies published in recent decades.
  • Analysis of research investigating the role of miRNAs in FMF pathogenesis.
  • Examination of studies evaluating miRNAs for diagnostic and therapeutic applications in FMF.

Main Results:

  • Evidence suggests that miRNAs play a significant role in the epigenetic regulation underlying FMF.
  • Specific miRNAs have been identified as potential regulators of MEFV gene expression in FMF patients.
  • miRNAs show promise as non-invasive biomarkers for FMF diagnosis and as targets for novel therapies.

Conclusions:

  • MicroRNAs are crucial epigenetic regulators implicated in the pathogenesis of Familial Mediterranean Fever (FMF).
  • Further research into miRNA profiles could lead to improved diagnostic tools and targeted therapeutic strategies for FMF.
  • miRNAs represent a promising avenue for advancing FMF management and patient outcomes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
27
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K